cannabinoid hyperemesis syndrome

First described in 2004.

cannabinoid hyperemesis syndrome (uncountable)

1. (medicine, pathology) A syndrome sometimes resulting from cannabis use, characterized by recurrent nausea, hyperemesis, and abdominal pain.

   Synonym: CHS

   • 2019, Catherine C. Crone, Jeanne M. Lackamp, Andrew R. Alkis, 19: Gastrointestinal Disorders, James L. Levenson (editor), Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry, 3rd Edition, American Psychiatric Association Publishing, page 535,

     Cannabinoid hyperemesis syndrome is sometimes mistaken for idiopathic cyclic vomiting syndrome, delaying appropriate treatment.

   • 2019, Mari J. Wirfs, The APRN and PA's Complete Guide to Prescribing Drug Therapy 2020, Springer, page 73:

     Comment: cannabinoid hyperemesis syndrome (CHS) is indicated by recurrent episodes of refractory nausea and vomiting with vague diffuse abdominal pain (accompanied by compulsive, frequent, hot baths or showers for relief of abdominal pain; these behaviors are thought to be learned through their cyclical periods of emesis) in the context of chronic cannabis use (at least weekly for >2 years).

   • 2023, Ivan A. Ross, Plant-Based Therapeutics, Volume 1: Cannabis sativa, Springer Publishing, page 343,

     Cannabinoid hyperemesis syndrome can be challenging to differentiate from hyperemesis gravidarum.

• scromiting (informal, a characteristic symptom)